Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate whether myo-inositol supplementation may reduce gestational diabetes mellitus (GDM) rate in overweight women. METHODS: In an open-label, randomized trial, myo-inositol (2 g plus 200 μg folic acid twice a day) or placebo (200 μg folic acid twice a day) was administered from the first trimester to delivery in pregnant overweight non-obese women (pre-pregnancy body mass index ≥ 25 and < 30 kg/m(2)). The primary outcome was the incidence of GDM. RESULTS: From January 2012 to December 2014, 220 pregnant women were randomized at two Italian University hospitals, 110 to myo-inositol and 110 to placebo. The incidence of GDM was significantly lower in the myo-inositol group compared to the placebo group (11.6% versus 27.4%, respectively, p = 0.004). Myo-inositol treatment was associated with a 67% risk reduction of developing GDM (OR 0.33; 95% CI 0.15-0.70). CONCLUSIONS: Myo-inositol supplementation, administered since early pregnancy, reduces GDM incidence in overweight non-obese women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
ACOG Practice Bulletin No. 30: Gestational Diabetes
(2001) · Obstetrics & Gynecology · doi:10.1097/00006250-200109000-00037 · Cited by 301
RetractedHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“From the beginning of 2010, after the publication of the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study results [2], we follow the recommendations of the International Association of Diabetes in Pregnancy Study Group (IADPSG) [3] later modified in 2011 by American Diabetes Association (ADA) [4].”
InfluentialSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“It is common knowledge that the increased visceral adipose tissue regulates the glucose homeostasis, the energy metabolism, the immune system the coagulation and the blood pressure [15].”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women
Catalano, P. M., Tyzbir, E. D., Roman, N. M., Amini, S. B., & Sims, E. A. H. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90012-g · Cited by 709
Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489
Genazzani, A. D., Lanzoni, C., Ricchieri, F., & Jasonni, V. M. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801893232 · Cited by 221
Diet and exercise interventions for preventing gestational diabetes mellitus
Bain, E., Crane, M., Tieu, J., Han, S., Crowther, C. A., & Middleton, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010443.pub2 · Cited by 188
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Gestational Diabetes Mellitus in Europe: A Systematic Review and Meta-Analysis of Prevalence Studies
Paulo, M. S., Abdo, N. M., Bettencourt-Silva, R., & Al-Rifai, R. H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.691033 · Cited by 181
Griffith, R. J., Alsweiler, J., Moore, A. E., Brown, S., Middleton, P., Shepherd, E., & Crowther, C. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012394.pub3 · Cited by 149
The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
Pintaudi, B., Di Vieste, G., & Bonomo, M. (2016) · International Journal of Endocrinology · doi:10.1155/2016/9132052 · Cited by 117
Self-citation
Metadata
- Authors
- Santamaria, A., Di Benedetto, A., Petrella, E., Pintaudi, B., Corrado, F., D’Anna, R., Neri, I., & Facchinetti, F.
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2015-12-23
- Volume
- 29
- Issue
- 19
- Pages
- 3234-3237
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2220918160
- Cited by
- 114
- References
- 9
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. https://app.cochat.ai/papers/10.3109/14767058.2015.1121478
- The paper
- Santamaria, A., Di Benedetto, A., Petrella, E., Pintaudi, B., Corrado, F., D’Anna, R., Neri, I., & Facchinetti, F. (2016). Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.3109/14767058.2015.1121478
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.